✦ LIBER ✦

Chronic hepatitis in young persons, with or without intermittent jaundice1

✍ Scribed by POLACK, EDMUND

Book ID: 114678843
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Weight: 379 KB
Volume: 93
Category: Article
ISSN: 0001-6101
DOI: 10.1111/j.0954-6820.1937.tb17636.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic lidocaine metabolism in chronic

Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis

✍ Gloria Taliani; Franca Duca; Rosina Lecce; Donatella Livoli; Caterina Pasquazzi; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

Hepatic lidocaine metabolism in chronic

Hepatic lidocaine metabolism in chronic hepatitis C virus hepatitis with or without steatosis

✍ TALIANI, G 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

P-373 Chronic active hepatitis B patient

P-373 Chronic active hepatitis B patients of acute exacerbation with or without abrupt onset of severe jaundice

✍ Heon Ju Lee; Jeong Ill Suh 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy and side effects of intermitten

Efficacy and side effects of intermittent recombinant interferon-α2a in chronic aggressive hepatitis C: With or without initial daily administration

✍ HIDEKAZU ITOH; HIDENORI NAKATA; YUKIHIRO YOKOYA; SHOICHI NAKASHIMA; TETSUJI YAMA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Randomized trial of interferon beta-1a w

Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C

✍ Henry L. Y. Chan; Hong Ren; Wan C. Chow; Theodore Wee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 1 views

Phase 1b study of pegylated interferon l

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

✍ Andrew J. Muir; Mitchell L. Shiffman; Atif Zaman; Boris Yoffe; Andrew de la Torr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Interferon lambda 1 (IFN-k1) is a type III IFN that produces intracellular responses similar to those of IFN-a but in fewer cell types because of differences in the receptor distribution pattern, and this could potentially result in an improved safety profile. This was an open-label three-part study